KUALA LUMPUR: Healthcare companies with strong cost management are expected to benefit as Malaysia moves towards more transparent hospital billing and faces rising healthcare demand from an ageing population.

RHB Investment Bank Bhd (RHB IB) has selected five companies, namely Binastra Corp Bhd, Eco-Shop Marketing Bhd, Kelington Group Bhd, LAC Med Bhd, and MR DIY Group (M) Bhd, as its top environmental, social, and governance (ESG) investment "Diamonds in the Rough" for 2026.

KUALA LUMPUR: RHB Investment Bank Bhd (RHB IB) has selected five Malaysian companies, namely Binastra Corporation Bhd, Eco-Shop Marketing Bhd, Kelington Group Bhd, LAC Med Bhd, and MR DIY Group (M) Bhd, as its top environmental, social, and governance (ESG) investment "Diamonds in the Rough" for 2026.

LAC医疗（LACMED,5341,主板医疗保健组）专注于提供医疗设备及软体系统整合等服务，分析员认为，随着经常收入基础扩大，该公司的盈利可见度已跟着增强。乐天交易分析员在报告中说，在大马医疗旅游年2026（MYMT 2026）政策带动之下，我国的目标是到2030年将医疗旅游收入从2024年的27亿2000万令吉提升至120亿令吉，这需要业者持续扩充医院及增加医疗设备投资。“LAC医疗拥有涵盖影像、诊断及资讯通讯科技（ICT）整合等11个品牌组合，有机会成为医院资本开销与营运开销供应链直接且...

THE Securities Commission Malaysia (SC) is following the lead of regional counterparts in Japan, South Korea and Singapore by launching a “value up” programme to boost stock valua­tions in the local bourse. In the recently launched 4th Capital Market Master Plan (CMP4), SC announced the...

Malaysia's healthcare sector is expected to remain a preferred defensive play in 2026, underpinned by resilient domestic demand, rising revenue intensity and stronger earnings visibility.

马股保健股LAC Med（LACMED，5341，主板保健股）近期股价从1.25令吉高位回落至80仙水平，但基本面依然获得投行力挺。兴业投行在最新报告中指出，LAC Med不仅是大马医疗保健扩张的主要受益者，其不断增长的经常性收入更是一大亮点。特别是公司拿下了飞利浦（Philips）的MRI和CT扫描仪维修合约，这类大型设备服务费极具吸引力。此外，集团在印尼的扩展步伐加快，版图已延伸至苏门答腊和泗水等地。管理层指出，虽然面临潜在的通胀压力，但成本可转嫁给客户。投行认为，近...

乐天交易研究主管余贤彬在今日的线上汇报会中指出，在目前水平下，大马经济整体仍有能力应对油价上涨，并且相较一些区域国家，大马的抗冲击能力更强。...

LAC Med Bhd is projected to register 20%, 21%, and 13% earnings growth for financial years (FY25) to FY27 with a three-year compounded annual growth rate of 18.2%.

（吉隆坡19日讯）兴业小盘东盟研究对LAC Med Bhd（KL:LACMED）展开研究，认为该股是马来西亚医疗保健现代化进程的代表股。

兴业投行研究首次追踪LAC Med（LACMED，5341，主板保健股），称该公司为大马医疗现代化的代表企业。...

RHB Small Cap Asean Research sees LAC Med Bhd (KL:LACMED) as a play on Malaysia’s healthcare modernisation, assigning an 13% upside in its initiation report on the company which was listed on the Main Market of Bursa Malaysia in December 2025.

LAC Med Bhd (KL:LACMED), en route to list on the Main Market of Bursa Malaysia on Dec 10, is positioning itself not as another medical equipment distributor but as a specialist in high-value, highly specialised machines — a space dominated globally by only a handful of manufacturers. Th...

INVESTORS will have a busy week ahead as four companies are set to make their debut on Bursa Malaysia — building materials distributor BMS Holdings Bhd (KL:BMS), oil and gas shipping firm Orkim Bhd (KL:ORKIM), renewable energy player Wasco Greenergy Bhd (KL:GENERGY) and medical equipment distribu...

KUALA LUMPUR: Bursa Malaysia memulakan dagangan dengan nada lebih positif hari ini, selari dengan prestasi kebanyakan saham di Wall Street yang ditutup tinggi.

KUALA LUMPUR: Bursa Malaysia edged higher in early trade, following mostly stronger sessions on Wall Street overnight.

LAC Med Bhd made a steady debut on the Main Market of Bursa Malaysia yesterday, opening unchanged at its initial public offering (IPO) price of 75 sen amid brisk early trading.

（吉隆坡10日讯）医疗器械和综合解决方案供应商——LAC医疗（LACMED,5341,主板医疗保健组）今天在马股登场，开盘价报75仙，与发售价持平，最高曾升至79仙。闭市时，LAC医疗溢价1.5仙或2%，报76.5仙，交投量达到4885万8500股。LAC医疗集团首席执行员刘任堡在出席上市仪式后表示，今日在马股主板上市是集团的转折点，并感谢市场给予的支持，承诺将通过协助医疗机构优化资产，强化经常性收入基础。关于该公司进军印尼业务，刘任堡指出，印尼业务投入运作，同时上一季已经认列营收，预计明...

KUALA LUMPUR: Bursa Malaysia’s key index ended lower today, in line with most regional markets, amid mixed signals from Wall Street as investors turned cautious ahead of the highly anticipated United States Federal Reserve’s (Fed) policy announcement later tonight.